Friday, October 15, 2010

NUTRITION PARKINSONS DISEASE NUTRITIONAL SUPPLEMENTS Charlotte Waterworth Parkinson's disease is a progressive neurological disease that affects nearly 1 million people in the U.S., according to the Parkinson's Disease Foundation. People affected by the disease may experience stiffness in the limbs, tremor, difficulty moving and impaired balance and coordination. Parkinson's disease occurs when cells that produce the neurotransmitter called dopamine, start to die. As a result, dopamine levels in the brain fall, which in turn leads to movement and coordination problems. There is no cure for Parkinson's disease but it can be managed with medication. Nutritional supplements may also play a role in Parkinson's disease management; however research findings are somewhat inconclusive. Always check with your doctor before taking supplements. Coenzyme Q10 Coenzyme Q10 is an antioxidant that plays an important role in energy production. It occurs naturally in every cell of the body. It plays a particularly important for the mitochondrial bodies found in every cell as mitochondria are responsible for converting food into energy. According to the charity, Parkinson's UK, people with Parkinson's disease have less coenzyme Q10 in their cells than people who don't have the condition. They also have impaired mitochondrial function, which leads to an increase in free radicals, which cause cell damage. Since coenzyme Q10 is an antioxidant, it can neutralize free-radical damage. Coenzyme Q10 is found in small quantities in some foods, though Parkinson's UK notes that taking a coenzyme Q10 supplement is a more effective way of obtaining the antioxidant. Creatine Creatine is an antioxidant that improves mitochondrial function and helps protect brain cells from free-radical damage. Creatine has been shown to prevent the loss dopamine-producing brain cells in a mouse model of Parkinson's disease. The benefit to humans has not been conclusively proved. In 2007, scientists at Rush University Medical Center initiated a clinical trial to determine whether taking a creatine supplement can slow disease progression, reports Medical News Today. According to Rush University Medical Center, the study is expected to last for at least five years to accurately determine creatine's effect on disease progression.

Vitamins According to Medical News Today, a study published in "The Lancet Neurology" in2005, vitamin E may reduce the risk the of developing Parkinson's disease. Lead author, Dr. Mayhar Etminan from the Royal Victoria Hospital in Quebec, says that the benefits noted during the study were confined to vitamin E obtained through the diet. Dr. Etminan said that no definitive conclusions could be made as to whether vitamin E supplements would have the same benefit. Earlier research, published in1991 in the "Annals of Neurology," found that administering a high dose of vitamins E and C to patients with Parkinson's delayed disease progression. To learn more about the effects of nutrition on Parkinsons disease join The Parkinson Research Foundation in Deerfield Beach,Florida where it will be presenting a conference at the Hilton Deerfield Beach Florida on November 1st. Each year the Parkinson Research Foundation puts on educational conferences and programs such as this one to provide Parkinsons disease patients and caregivers with an opportunity to learn about the latest drugs and treatments for Parkinsons disease that can enhance their lives. A secondary objective is to provide a forum for patients and caregivers to share their concerns and successes with Parkinsons experts and other local patients.
Copyright 2003-2011 Parkinson Research Foundation, Inc. All rights reserved worldwide.

Disclaimer Privacy
This national website which is dedicated to Parkinson's disease is also your ultimate resource for information on Parkinson's Research, PD Symptoms, Motor symptoms, Non-Motor Symptoms, Incidence, Related diseases, Parkinson-Plus diseases, Pathology, Pathophysiology, Genetic, Toxins, Head trauma, Treatment, Pharmacological Treatments, Levodopa, Dopamine Agonists, MAO-B Inhibitor, SSRI's and SSNRI's, Surgical Interventions, Nutrients, Physical exercise, Prognosis, References, External links, Eponymous diseases, Geriatrics, Zelapar, Restless Leg Syndrome, and related Neurological disorders. Although many contributions are American and from Canada, the site seeks to support patients, caregivers, doctors and researchers worldwide.